Xoft

Radiation Therapy for Skin Cancer

As seen on KGO-TV San Francisco (below)

  EBXIn March 2010, we began offering Xoft Electronic Brachytherapy (eBx), a breakthrough radiation therapy for early stage breast cancer, skin cancer, and some gynecologic cancers. Xoft eBx is an alternative to radioactive isotope-based brachytherapy. It utilizes a miniaturized X-ray source to deliver precisely localized, high dose radiation to the target area, at low energy.

Treatment can be performed without the need for a shielded room, allowing the radiation oncologist and other medical personnel to be present during treatment delivery which can minimize patient anxiety. Xoft eBx allows for the radiation to be ‘more tightly’ focused around the tumor target which helps protect healthy organs and tissue. One of the biggest benefits to Xoft eBx is that is it requires fewer sessions than traditional radiation. Treatment for early stage breast cancer, skin cancer, and some gynecologic cancers can often be accomplished in as little as 5 sessions. Xoft eBx eliminates the use of radioactive isotopes, resulting in less exposure to radiation, fewer side effects, and excellent outcomes for patients.

Skin electronic brachytherapy (eBx) is an innovative, patient-friendly option for non-melanoma skin cancer (NMSC) treatment. By delivering a precise dose of targeted radiation directly to the area, skin eBx offers suitable patients a non-surgical, scar-free solution while limiting exposure to surrounding healthy tissue. Skin eBx provides an effective and convenient option allowing patients to return to normal activities immediately with no downtime.

One in five people will develop skin cancer in their lifetime, with more than 5.4 million cases diagnosed annually in the U.S. The majority of cancers appear on sun-exposed areas such as the face, scalp, nose, ears, hands, arms and legs. If you have been diagnosed with NMSC, such as basal or squamous cell carcinoma, you may have concerns about scarring, wound healing or preserving functionality in anatomically challenging areas.

What are the benefits of skin eBx?

Skin eBx provides patients with a targeted, non-invasive alternative to surgery for NMSC treatment. While surgery is considered to be the standard of care for NMSC, for some patients, surgery is not an option or a preference. A completely non-invasive approach, no cutting, bleeding or stitching is required with skin eBx, offering reduced risk of complications compared to surgery. Skin eBx offers patients and physicians a safe and effective treatment option for NMSC with valuable benefits including:

·      Excellent clinical and cosmetic results

·      Ideal for challenging anatomic locations

·      Precise targeting

·      No lifestyle restrictions

·      Quick treatment sessions

·      No pain, anesthesia, cutting, bleeding or stitching

·      No need for post-treatment reconstructive surgeries

·      Patients with lesions in anatomically challenging locations

·      Patients who prefer an alternative to surgery

·      Patients who are not surgical candidates due to medical comorbidities or other health issues such as diabetes, peripheral vascular disease or blood thinning medication

·      Patients with higher-risk lesions, including features such as positive margins, requiring adjunct therapy to surgery

·      Patients with busy schedules

 

DVO on KGO-TV San Francisco

A technology developed in the Bay Area is now being used as an alternative therapy for treating the most common form of skin cancer. There’s now a non-surgical option to consider.

“It was right in my right ear, it was like four little spots,” said skin cancer patient L.J. Hauss.

When Hauss was diagnosed with squamous cell carcinoma, the first option was surgery.

“He said you could do an operation with a skin graft and that would take a long time to heal,” said Hauss.

Instead, Hauss’ doctors turned an alternative for treating common types of carcinoma. It’s a form of precisely targeted radiation known as brachytherapy, which normally involves the placement radioactive pellets near the site of the cancer. But radiation oncologists from Diablo Valley Oncology, says this system, called Axxent, works differently.

  Click to read full article and watch video.